Home  >  Products  >  UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats ) Blocking Peptide (the C terminal of UACA)(100ug)
UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats ) Blocking Peptide (the C terminal of UACA)(100ug)

UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats ) Blocking Peptide (the C terminal of UACA)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-UACA Antibody (ARP62098_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62098
Size: 100ug
Weight: 154kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: UACA regulates APAF1 expression and plays an important role in the regulation of stress-induced apoptosis. It promotes apoptosis by regulating three pathways, apoptosome up-regulation, LGALS3/galectin-3 down-regulation and NF-kappa-B inactivation. It regulates the redistribution of APAF1 into the nucleus after proapoptotic stress and down-regulates the expression of LGALS3 by inhibiting NFKB1.
Alternative names: FLJ10128; KIAA1561; MGC141967; MGC141969; NUCLING
See Full Product Listings >